706 related articles for article (PubMed ID: 25412782)
1. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
Ryan C; Kirby B
Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782
[TBL] [Abstract][Full Text] [Related]
2. Psoriasis and cardiovascular disorders.
Ryan C; Menter A
G Ital Dermatol Venereol; 2012 Apr; 147(2):179-87. PubMed ID: 22481581
[TBL] [Abstract][Full Text] [Related]
3. Psoriasis and metabolic syndrome.
Takahashi H; Iizuka H
J Dermatol; 2012 Mar; 39(3):212-8. PubMed ID: 22035413
[TBL] [Abstract][Full Text] [Related]
4. Metabolic comorbidities and psoriasis.
Gisondi P; Ferrazzi A; Girolomoni G
Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis and cardiovascular disorders.
Frieder J; Ryan C
G Ital Dermatol Venereol; 2016 Dec; 151(6):678-693. PubMed ID: 27627099
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis and cardiovascular comorbidities with emphasis in Asia.
Chu TW; Tsai TF
G Ital Dermatol Venereol; 2012 Apr; 147(2):189-202. PubMed ID: 22481582
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis as the marker of underlying systemic disease.
Kourosh AS; Miner A; Menter A
Skin Therapy Lett; 2008 Feb; 13(1):1-5. PubMed ID: 18357363
[TBL] [Abstract][Full Text] [Related]
8. [Systemic therapy of psoriasis].
Altmeyer P; Nüchel C
Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1605-7. PubMed ID: 9011488
[No Abstract] [Full Text] [Related]
9. Psoriasis as a systemic disease.
Grozdev I; Korman N; Tsankov N
Clin Dermatol; 2014; 32(3):343-50. PubMed ID: 24767182
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.
Hu SC; Lan CE
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065479
[TBL] [Abstract][Full Text] [Related]
11. From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies.
Hugh J; Van Voorhees AS; Nijhawan RI; Bagel J; Lebwohl M; Blauvelt A; Hsu S; Weinberg JM
J Am Acad Dermatol; 2014 Jan; 70(1):168-77. PubMed ID: 24184141
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study.
Mahé E; Reguiai Z; Barthelemy H; Quiles-Tsimaratos N; Chaby G; Girard C; Estève E; Maccari F; Descamps V; Schmutz JL; Begon E; Bravard P; Maillard H; Boyé T; Beauchet A; Sigal ML;
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):151-9. PubMed ID: 23279264
[TBL] [Abstract][Full Text] [Related]
13. Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study.
Boehncke S; Salgo R; Garbaraviciene J; Beschmann H; Hardt K; Diehl S; Fichtlscherer S; Thaçi D; Boehncke WH
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1187-93. PubMed ID: 21241371
[TBL] [Abstract][Full Text] [Related]
14. How are we using systemic drugs to treat psoriasis in children? An insight into current clinical U.K. practice.
Burden-Teh E; Lam ML; Taibjee SM; Taylor A; Webster S; Dolman S; Jury C; Caruana D; Darne S; Carmichael A; Natarajan S; McPherson T; Moore A; Katugampola R; Kalavala M; Al-Ismail D; Richards L; Jones V; Batul Syed S; Glover M; Hughes J; Anderson E; Hughes B; Helbling I; Murphy R
Br J Dermatol; 2015 Aug; 173(2):614-8. PubMed ID: 25601323
[No Abstract] [Full Text] [Related]
15. Nodular melanoma arising in a patient treated with anti-tumor necrosis factor alpha antagonists.
Carlesimo M; La Pietra M; Arcese A; Di Russo PP; Mari E; Gamba A; Orsini D; Camplone G
Int J Dermatol; 2012 Oct; 51(10):1234-6. PubMed ID: 22416995
[No Abstract] [Full Text] [Related]
16. Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
Kojanova M; Fialova J; Cetkovska P; Gkalpakiotis S; Jircikova J; Dolezal T; Arenberger P;
Int J Dermatol; 2017 Apr; 56(4):428-434. PubMed ID: 28181669
[TBL] [Abstract][Full Text] [Related]
17. [Cardiovascular risk profile of patients with psoriasis].
Di Lisi D; Macaione F; Corrado E; Bonura F; Novo G; Peritore A; Meschisi M; Cuttitta F; Bongiorno MR; Novo S
Recenti Prog Med; 2013 Mar; 104(3):102-5. PubMed ID: 23548953
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis.
Burfield L; Burden AD
J R Coll Physicians Edinb; 2013; 43(4):334-8; quiz 339. PubMed ID: 24350319
[TBL] [Abstract][Full Text] [Related]
19. [Psoriasis, a systemic disease?].
Puig-Sanz L
Actas Dermosifiliogr; 2007; 98(6):396-402. PubMed ID: 17663929
[TBL] [Abstract][Full Text] [Related]
20. The concept of psoriasis as a systemic inflammation: implications for disease management.
Reich K
J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():3-11. PubMed ID: 22356630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
